The main hypothesis of the HEPACORT study is that upon diagnosis of endogenous Cushing's syndrome, significant liver fibrosis may be present, particularly in the most severe forms of Cushing's syndrome.
the HEPACORT study is the first exploratory study to assess the severity of liver fibrosis in patients with Cushing's syndrome or suspected of presenting by Magnetic Resonance Elastography (MRE).
age ≥ 18 years old;
Person affiliated to a social security scheme or beneficiary of such a scheme;
Person having received complete information on the organization of the research and having signed informed consent;
Person having carried out a preliminary clinical examination adapted to the research.
Person having taken corticosteroid therapy for more than 3 months during the 2 years preceding inclusion;
Person having received corticosteroid therapy of shorter duration with discontinuation less than one month before inclusion;
Person having taken anticortisolic treatment for more than 3 months during the 2 years preceding inclusion;
Person with chronic liver disease;